Fonar Corp (FONR)
16.31
+0.05
(+0.31%)
USD |
NASDAQ |
May 03, 16:00
16.54
+0.23
(+1.41%)
After-Hours: 20:00
Fonar Free Cash Flow: 12.18M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.18M |
| September 30, 2023 | 10.93M |
| June 30, 2023 | 10.13M |
| March 31, 2023 | 10.93M |
| December 31, 2022 | 11.44M |
| September 30, 2022 | 12.37M |
| June 30, 2022 | 10.67M |
| March 31, 2022 | 11.55M |
| December 31, 2021 | 10.60M |
| September 30, 2021 | 10.95M |
| June 30, 2021 | 14.27M |
| March 31, 2021 | 14.48M |
| December 31, 2020 | 14.61M |
| September 30, 2020 | 14.32M |
| June 30, 2020 | 12.76M |
| March 31, 2020 | 13.24M |
| December 31, 2019 | 14.08M |
| September 30, 2019 | 14.46M |
| June 30, 2019 | 15.96M |
| March 31, 2019 | 15.90M |
| December 31, 2018 | 16.24M |
| September 30, 2018 | 16.11M |
| June 30, 2018 | 15.85M |
| March 31, 2018 | 16.20M |
| December 31, 2017 | 15.71M |
| Date | Value |
|---|---|
| September 30, 2017 | 14.13M |
| June 30, 2017 | 13.80M |
| March 31, 2017 | 13.62M |
| December 31, 2016 | 13.39M |
| September 30, 2016 | 15.10M |
| June 30, 2016 | 15.79M |
| March 31, 2016 | 14.39M |
| December 31, 2015 | 14.67M |
| September 30, 2015 | 13.58M |
| June 30, 2015 | 13.00M |
| March 31, 2015 | 12.04M |
| December 31, 2014 | 11.92M |
| September 30, 2014 | 11.75M |
| June 30, 2014 | 12.56M |
| March 31, 2014 | 9.395M |
| December 31, 2013 | 8.949M |
| September 30, 2013 | 8.488M |
| June 30, 2013 | 6.244M |
| March 31, 2013 | 8.237M |
| December 31, 2012 | 8.085M |
| September 30, 2012 | 6.699M |
| June 30, 2012 | 6.186M |
| March 31, 2012 | 4.895M |
| December 31, 2011 | 3.054M |
| September 30, 2011 | 3.180M |
Free Cash Flow Range, Past 5 Years
10.13M
Minimum
Jun 2023
15.96M
Maximum
Jun 2019
12.63M
Average
12.37M
Median
Sep 2022
Free Cash Flow Benchmarks
| XWELL Inc | -18.45M |
| ProPhase Labs Inc | -14.50M |
| Applied DNA Sciences Inc | -7.592M |
| Veracyte Inc | 34.26M |
| OncoCyte Corp | -23.61M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 4.071M |
| Cash from Investing (Quarterly) | -0.133M |
| Cash from Financing (Quarterly) | -2.406M |
| Free Cash Flow Per Share (Quarterly) | 0.5998 |
| Free Cash Flow to Equity (Quarterly) | 3.95M |
| Free Cash Flow to Firm (Quarterly) | 3.946M |
| Free Cash Flow Yield | 11.26% |